Jang JY - Search Results

1

Serial measurement of surface expressions of CD63, P-selectin and CD40 ligand on platelets in atherosclerotic ischemic stroke. A possible role of CD40 ligand on platelets in atherosclerotic ischemic stroke.

Cha JK, Jeong MH, Jang JY, Bae HR, Lim YJ, Kim JS, Kim SH, Kim JW. Cha JK, et al. Among authors: jang jy. Cerebrovasc Dis. 2003;16(4):376-82. doi: 10.1159/000072560. Cerebrovasc Dis. 2003. PMID: 13130179

2

Loss of mitochondrial membrane potential and caspase activation enhance apoptosis in irradiated K562 cells treated with herbimycin A.

Jo WS, Jeong MH, Jin YH, Jang JY, Nam BH, Son SH, Choi SS, Yoo YH, Kang CD, Lee JD, Jeong SJ. Jo WS, et al. Among authors: jang jy. Int J Radiat Biol. 2005 Jul;81(7):531-43. doi: 10.1080/09553000500303773. Int J Radiat Biol. 2005. PMID: 16263657

3

Dichloromethane fraction of Cimicifuga heracleifolia decreases the level of melanin synthesis by activating the ERK or AKT signaling pathway in B16F10 cells.

Jang JY, Lee JH, Kang BW, Chung KT, Choi YH, Choi BT. Jang JY, et al. Exp Dermatol. 2009 Mar;18(3):232-7. doi: 10.1111/j.1600-0625.2008.00794.x. Epub 2008 Sep 18. Exp Dermatol. 2009. PMID: 18803655

4

Partially purified Curcuma longa inhibits alpha-melanocyte-stimulating hormone-stimulated melanogenesis through extracellular signal-regulated kinase or Akt activation-mediated signalling in B16F10 cells.

Jang JY, Lee JH, Jeong SY, Chung KT, Choi YH, Choi BT. Jang JY, et al. Exp Dermatol. 2009 Aug;18(8):689-94. doi: 10.1111/j.1600-0625.2009.00857.x. Epub 2009 Mar 7. Exp Dermatol. 2009. PMID: 19469902

5

The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study.

Rangelova E, Stoop TF, van Ramshorst TME, Ali M, van Bodegraven EA, Javed AA, Hashimoto D, Steyerberg E, Banerjee A, Jain A, Sauvanet A, Serrablo A, Giani A, Giardino A, Zerbi A, Arshad A, Wijma AG, Coratti A, Zironda A, Socratous A, Rojas A, Halimi A, Ejaz A, Oba A, Patel BY, Björnsson B, Reames BN, Tingstedt B, Goh BKP, Payá-Llorente C, Domingo Del Pozo C, González-Abós C, Medin C, van Eijck CHJ, de Ponthaud C, Takishita C, Schwabl C, Månsson C, Ricci C, Thiels CA, Douchi D, Hughes DL, Kilburn D, Flanking D, Kleive D, Sousa Silva D, Edil BH, Pando E, Moltzer E, Kauffman EF, Warren E, Bozkurt E, Sparrelid E, Thoma E, Verkolf E, Ausania F, Giannone F, Hüttner FJ, Burdio F, Souche FR, Berrevoet F, Daams F, Motoi F, Saliba G, Kazemier G, Roeyen G, Nappo G, Butturini G, Ferrari G, Kito Fusai G, Honda G, Sergeant G, Karteszi H, Takami H, Suto H, Matsumoto I, Mora-Oliver I, Frigerio I, Fabre JM, Chen J, Sham JG, Davide J, Urdzik J, de Martino J, Nielsen K, Okano K, Kamei K, Okada K, Tanaka K, Labori KJ, Goodsell KE, Alberici L, Webber L, Kirkov L, de Franco L, Miyashita M, Maglione M, Gramellini M, Ramera M, João Amaral M, Ramaekers M, Truty MJ, van Dam MA, Stommel MWJ, Petrikowski M, … See abstract for full author list ➔ Rangelova E, et al. Among authors: jang jy. Ann Oncol. 2025 Jan 13:S0923-7534(25)00004-3. doi: 10.1016/j.annonc.2024.12.015. Online ahead of print. Ann Oncol. 2025. PMID: 39814200

6

ASO Author Reflections: Is There an Extra Benefit of Adding Neoadjuvant Radiotherapy to Chemotherapy in Patients with (Borderline) Resectable Pancreatic Cancer?

Yun WG, Jang JY. Yun WG, et al. Among authors: jang jy. Ann Surg Oncol. 2025 Jan 15. doi: 10.1245/s10434-024-16829-x. Online ahead of print. Ann Surg Oncol. 2025. PMID: 39812917 No abstract available.

7

The Roles of Ninjurin1 and Estrogen in Modulating AOM/DSS-Induced Colitis-Associated Colorectal Cancer in Male Mice.

Song CH, Kim N, Nam RH, Jang JY, Kim EH, Ha S, Shin E, Lee HN, Choi H, Kim KW, Jeon S, Oh GT. Song CH, et al. Among authors: jang jy. Cancer Res Treat. 2025 Jan 13. doi: 10.4143/crt.2024.959. Online ahead of print. Cancer Res Treat. 2025. PMID: 39810489

8

Efficacy of Neoadjuvant Radiotherapy After Chemotherapy and the Optimal Interval from Radiotherapy to Surgery for Borderline Resectable and Resectable Pancreatic Cancer.

Yun WG, Chae YS, Han Y, Jung HS, Cho YJ, Kang HC, Kwon W, Park JS, Chie EK, Jang JY. Yun WG, et al. Among authors: jang jy. Ann Surg Oncol. 2025 Jan 14. doi: 10.1245/s10434-024-16743-2. Online ahead of print. Ann Surg Oncol. 2025. PMID: 39808212

9

Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C.

Ryu T, Chang Y, Jeong SW, Yoo JJ, Lee SH, Kim SG, Kim YS, Kim HS, Kim SU, Jang JY. Ryu T, et al. Among authors: jang jy. Clin Mol Hepatol. 2025 Jan 9. doi: 10.3350/cmh.2024.0904. Online ahead of print. Clin Mol Hepatol. 2025. PMID: 39788108 Free article.

10

Multiomic quantification of the KRAS mutation dosage improves the preoperative prediction of survival and recurrence in patients with pancreatic ductal adenocarcinoma.

Yun WG, Kim D, Han Y, Kwon W, Lee SG, Jang JY, Park D. Yun WG, et al. Among authors: jang jy. Exp Mol Med. 2025 Jan 8. doi: 10.1038/s12276-024-01382-0. Online ahead of print. Exp Mol Med. 2025. PMID: 39779977 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,671 results

Search Page

Filters